204 related articles for article (PubMed ID: 28223543)
21. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.
Scaffidi C; Schmitz I; Zha J; Korsmeyer SJ; Krammer PH; Peter ME
J Biol Chem; 1999 Aug; 274(32):22532-8. PubMed ID: 10428830
[TBL] [Abstract][Full Text] [Related]
22. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
Kohlhaas SL; Craxton A; Sun XM; Pinkoski MJ; Cohen GM
J Biol Chem; 2007 Apr; 282(17):12831-41. PubMed ID: 17327223
[TBL] [Abstract][Full Text] [Related]
23. Caspase-dependent and -independent activation of acid sphingomyelinase signaling.
Rotolo JA; Zhang J; Donepudi M; Lee H; Fuks Z; Kolesnick R
J Biol Chem; 2005 Jul; 280(28):26425-34. PubMed ID: 15849201
[TBL] [Abstract][Full Text] [Related]
24. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.
Wieder T; Essmann F; Prokop A; Schmelz K; Schulze-Osthoff K; Beyaert R; Dörken B; Daniel PT
Blood; 2001 Mar; 97(5):1378-87. PubMed ID: 11222383
[TBL] [Abstract][Full Text] [Related]
25. Protein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosis.
Gómez-Angelats M; Cidlowski JA
J Biol Chem; 2001 Nov; 276(48):44944-52. PubMed ID: 11581255
[TBL] [Abstract][Full Text] [Related]
26. Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases.
Brenner B; Ferlinz K; Grassmé H; Weller M; Koppenhoefer U; Dichgans J; Sandhoff K; Lang F; Gulbins E
Cell Death Differ; 1998 Jan; 5(1):29-37. PubMed ID: 10200443
[TBL] [Abstract][Full Text] [Related]
27. Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis.
Lavrik IN; Golks A; Baumann S; Krammer PH
Blood; 2006 Jul; 108(2):559-65. PubMed ID: 16822901
[TBL] [Abstract][Full Text] [Related]
28. CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells.
Tan L; Zhang C; Dematos J; Kuang L; Jung JU; Liang X
J Virol; 2016 Nov; 90(21):9782-9796. PubMed ID: 27558422
[TBL] [Abstract][Full Text] [Related]
29. HLA class II signals sensitize B lymphocytes to apoptosis via Fas/CD95 by increasing FADD recruitment to activated Fas and activation of caspases.
Blancheteau V; Charron D; Mooney N
Hum Immunol; 2002 May; 63(5):375-83. PubMed ID: 11975981
[TBL] [Abstract][Full Text] [Related]
30. Essential roles of PKA, iNOS, CD95/CD95L, and terminal caspases in suppression of eosinopoiesis by PGE2 and other cAMP-elevating agents.
de Luca B; Xavier-Elsas P; Barradas M; Luz RA; Queto T; Jones C; Arruda MA; Cunha TM; Cunha FQ; Gaspar-Elsas MI
ScientificWorldJournal; 2013; 2013():208705. PubMed ID: 24376378
[TBL] [Abstract][Full Text] [Related]
31. Activation of neutral sphingomyelinase participates in ethanol-induced apoptosis in Hep G2 cells.
Liu JJ; Wang JY; Hertervig E; Cheng Y; Nilsson A; Duan RD
Alcohol Alcohol; 2000; 35(6):569-73. PubMed ID: 11093963
[TBL] [Abstract][Full Text] [Related]
32. Distinct intracellular signaling in tumor necrosis factor-related apoptosis-inducing ligand- and CD95 ligand-mediated apoptosis.
Velthuis JH; Rouschop KM; De Bont HJ; Mulder GJ; Nagelkerke JF
J Biol Chem; 2002 Jul; 277(27):24631-7. PubMed ID: 11980895
[TBL] [Abstract][Full Text] [Related]
33. CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition.
Tepper AD; Cock JG; de Vries E; Borst J; van Blitterswijk WJ
J Biol Chem; 1997 Sep; 272(39):24308-12. PubMed ID: 9305886
[TBL] [Abstract][Full Text] [Related]
34. Reactive oxygen species limit neutrophil life span by activating death receptor signaling.
Scheel-Toellner D; Wang K; Craddock R; Webb PR; McGettrick HM; Assi LK; Parkes N; Clough LE; Gulbins E; Salmon M; Lord JM
Blood; 2004 Oct; 104(8):2557-64. PubMed ID: 15238425
[TBL] [Abstract][Full Text] [Related]
35. Increase of nuclear ceramide through caspase-3-dependent regulation of the "sphingomyelin cycle" in Fas-induced apoptosis.
Watanabe M; Kitano T; Kondo T; Yabu T; Taguchi Y; Tashima M; Umehara H; Domae N; Uchiyama T; Okazaki T
Cancer Res; 2004 Feb; 64(3):1000-7. PubMed ID: 14871831
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
[TBL] [Abstract][Full Text] [Related]
37. Ribavirin and alpha interferon enhance death receptor-mediated apoptosis and caspase activation in human hepatoma cells.
Schlosser SF; Schuler M; Berg CP; Lauber K; Schulze-Osthoff K; Schmahl FW; Wesselborg S
Antimicrob Agents Chemother; 2003 Jun; 47(6):1912-21. PubMed ID: 12760867
[TBL] [Abstract][Full Text] [Related]
38. Regulation of sphingomyelinases in cells of the oligodendrocyte lineage.
Testai FD; Landek MA; Dawson G
J Neurosci Res; 2004 Jan; 75(1):66-74. PubMed ID: 14689449
[TBL] [Abstract][Full Text] [Related]
39. Immunomagnetic isolation of tumor necrosis factor receptosomes.
Tchikov V; Schütze S
Methods Enzymol; 2008; 442():101-23. PubMed ID: 18662566
[TBL] [Abstract][Full Text] [Related]
40. CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase.
Cock JG; Tepper AD; de Vries E; van Blitterswijk WJ; Borst J
J Biol Chem; 1998 Mar; 273(13):7560-5. PubMed ID: 9516458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
